Under the Sisterhood
Dr. Beth Garner Women’s Health leader, clinician, and scientist on impacting millions of lives.
Today we’re getting under the hood of Dr. Beth Garner a mother, daughter, sister, Board Certified OBGYN, seasoned strategic- and business-minded executive, and corporate board member with a career-long focus on addressing unmet needs in conditions and issues that affect women’s health and quality of life.
Born and raised in Nigeria, she brings a global view to her work in both the corporate and non-profit worlds. Elizabeth (Beth) is currently the US Chief Scientific Officer of Ferring, a leading mid-size global company focused on reproductive and maternal health, microbiome and gastrointestinal therapeutics, and uro-oncology.
She is on the BODs of Kezar Life Sciences (KZR), which develops novel therapies for autoimmune diseases and cancer, and Sermonix Pharmaceuticals, focused on targeted breast cancer therapies. Beth was also recently appointed as the Chair of the Board of NUA Surgical, a start-up company dedicated to creating innovative surgical solutions in obstetrics and gynecology. Elizabeth serves on the Board and is the current President of the American Medical Women’s Association (AMWA), a professional organization whose mission is to advance women physicians, advocate for equity, and ensure excellence in healthcare.
Dr. Garner received joint M.D. and M.P.H. degrees from Harvard Medical and Public Health Schools. She trained in obstetrics and gynecology at Brigham and Women’s Massachusetts General Hospitals and completed a fellowship in gynecologic oncology at BWH/Dana Farber Cancer Institute. Prior to transitioning into industry, she was Assistant Professor at HMS, where she focused on academic clinical practice in gynecologic oncology, basic science ovarian cancer research, and teaching and mentorship of residency and fellowship trainees and medical students.
Elizabeth has extensive experience as a media spokesperson and is a frequent panelist and speaker on a range of topics including innovation and investment in women’s health, women’s leadership, diversity, equity, and inclusion (DEI), and diversity in clinical trials. She is an author of close to 40 peer-reviewed scientific papers. Garner is a 2019 and 2023 awardee of the PharmaVoice 100 Most Inspiring Individuals in the Life Sciences industry and was the 2022 recipient of the Woman in Science Award from the American Medical Women’s Association.
If you haven’t already, please give us a quick review and rating on Apple podcasts and Spotify and don’t forget you can follow us FaceBook, Instagram, Twitter and YouTube.
Today we’re getting under the hood of Dr. Beth Garner a mother, daughter, sister, Board Certified OBGYN, seasoned strategic- and business-minded executive, and corporate board member with a career-long focus on addressing unmet needs in conditions and issues that affect women’s health and quality of life.
Born and raised in Nigeria, she brings a global view to her work in both the corporate and non-profit worlds. Elizabeth (Beth) is currently the US Chief Scientific Officer of Ferring, a leading mid-size global company focused on reproductive and maternal health, microbiome and gastrointestinal therapeutics, and uro-oncology.
She is on the BODs of Kezar Life Sciences (KZR), which develops novel therapies for autoimmune diseases and cancer, and Sermonix Pharmaceuticals, focused on targeted breast cancer therapies. Beth was also recently appointed as the Chair of the Board of NUA Surgical, a start-up company dedicated to creating innovative surgical solutions in obstetrics and gynecology. Elizabeth serves on the Board and is the current President of the American Medical Women’s Association (AMWA), a professional organization whose mission is to advance women physicians, advocate for equity, and ensure excellence in healthcare.
Dr. Garner received joint M.D. and M.P.H. degrees from Harvard Medical and Public Health Schools. She trained in obstetrics and gynecology at Brigham and Women’s Massachusetts General Hospitals and completed a fellowship in gynecologic oncology at BWH/Dana Farber Cancer Institute. Prior to transitioning into industry, she was Assistant Professor at HMS, where she focused on academic clinical practice in gynecologic oncology, basic science ovarian cancer research, and teaching and mentorship of residency and fellowship trainees and medical students.
Elizabeth has extensive experience as a media spokesperson and is a frequent panelist and speaker on a range of topics including innovation and investment in women’s health, women’s leadership, diversity, equity, and inclusion (DEI), and diversity in clinical trials. She is an author of close to 40 peer-reviewed scientific papers. Garner is a 2019 and 2023 awardee of the PharmaVoice 100 Most Inspiring Individuals in the Life Sciences industry and was the 2022 recipient of the Woman in Science Award from the American Medical Women’s Association.
If you haven’t already, please give us a quick review and rating on Apple podcasts and Spotify and don’t forget you can follow us FaceBook, Instagram, Twitter and YouTube.